AstraZeneca in $400bn talks to buy Bristol Myers Squibb
Seven outlets independently confirm megadeal talks, but no BMS price data has landed yet.
What's happening
The Guardian, CNBC, Reuters (twice), and FT-sourced reports all say AstraZeneca held talks with Bristol Myers Squibb on a roughly $400 billion merger. The story broke and re-broke across a full day, with Reuters and CNBC both citing the FT as the original source and adding their own confirmations.
The numbers
Velocity 12.2 is the highest in this batch, breadth 3, and 37 recent mentions โ the loudest story on the board today. No BMS price/verdict was captured, though AstraZeneca shares reportedly fell 7% on the report.
Our read
Seven independent outlets converging on a specific dollar figure is not noise โ this is a corroborated deal story, not speculation from one source. Verdict: watch, pending confirmed BMS price action; the AZN drop suggests the market's first read favors the seller, not the acquirer. Watch for an official confirmation or denial from either company.
Sources we checked
- AstraZeneca holds talks with Bristol Myers Squibb over $400bn merger โ theguardian.com
- AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb โ cnbc.com
- AstraZeneca considering a $400 billion merger with Bristol Myers Squibb โ 36kr.com
- AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports โ CNBC
- AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says โ Reuters
- AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal, FT reports โ Reuters
- AstraZeneca Said to Discuss Merger with Bristol Myers Squibb โ 36kr.com
See today's live board
This story is frozen as published on August 3, 2026. The live board shows what is moving right now, scored against real money.
Open this story live โ See today's live boardMore Stocks stories
- SEC pauses Nasdaq bitcoin options after CME objection August 3, 2026
- Alibaba ships 2.4-trillion-parameter Qwen3.8-Max model August 3, 2026
- AstraZeneca shares drop 7% on Bristol Myers megadeal talk August 3, 2026
- DJT Slides as Trump Media's Bitcoin Buffer Shrinks August 3, 2026
- Microsoft's Azure Milestone Adds $450 Billion in a Day August 3, 2026
- Meta Chatter Is Thin and Contradicts the Price August 3, 2026
Research, not financial advice. Sort Brick reports what its data showed at the time of publication. It is not a recommendation to buy or sell anything โ you decide.